Folger Nolan Fleming Douglas Capital Management, Inc Bristol Myers Squibb CO Transaction History
Folger Nolan Fleming Douglas Capital Management, Inc
- $889 Million
- Q2 2024
A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 13,972 shares of BMY stock, worth $685,326. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,972
Previous 16,445
15.04%
Holding current value
$685,326
Previous $891,000
34.9%
% of portfolio
0.07%
Previous 0.1%
Shares
25 transactions
Others Institutions Holding BMY
# of Institutions
2,469Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$9.13 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$7.97 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.49 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$4.36 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.44 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...